Navigation Links
Journal of Managed Care Pharmacy recognizes Prime Therapeutics with two 2012 JMCP Award for Excellence Honorable Mentions
Date:5/7/2013

ST. PAUL, Minn., May 7, 2013 /PRNewswire/ -- Prime Therapeutics (Prime), a leading pharmacy benefit manager (PBM), announced today that it has been awarded two Honorable Mentions in the 2012 Award for Excellence from the Journal of Managed Care Pharmacy (JMCP).

One study examined the impact of generic drug discount programs on levothyroxine (a drug to treat low thyroid) pharmacy claims data. A second study reviewed members' medication use following the implementation of a rosiglitazone (a type 2 diabetes drug) safety prior authorization (PA) policy.

Pharmacies' Generic Drug Discount Programs - Potential Impact on PBM Claims Capture

Generic drug discount programs were popularized in 2006 when pharmacies such as Walmart began offering medications for as low as $4. While the programs reduce the cost of medicine for consumers, they may also reduce a PBM's ability to capture claims data, negatively impacting the ability to provide clinical programs and adherence reporting.

Prime compared claims from 3.5 million commercially insured members filling a levothyroxine prescription between January 1, 2006, and December 31, 2010. Researchers found an equivalent number of patients who did not continue a drug purchased at a non-membership pharmacy discount program, compared to a control group. On the other hand, those purchasing a generic through a membership program pharmacy appeared to have a small but statistically significantly higher rate of members who did not continue the drug.

"Although generic drug discount programs have been prevalent since 2008, it is a common concern that PBM and health plan prescription information is incomplete due to an unknown proportion of generic drug claims that are not submitted," said Patrick Gleason , PharmD, BCPS, FCCP and lead author and director of health outcomes for Prime. "These study results suggest that health insurers and PBMs should work to ensure that claims information is complete on pharmacies with membership drug discounts."

Authors of the study were: Alexandra Tungol , PharmD; Catherine I. Starner , PharmD, BCPS, CGP; Brent W. Gunderson , PharmD; Jeremy A. Schafer , PharmD, MBA; Yang Qiu , MS; and Gleason.

The study can be found at: http://www.amcp.org/WorkArea/DownloadAsset.aspx?id=15873

Rosiglitazone Prior Authorization Safety Policy

In the second study, Prime collaborated with Florida Blue to evaluate drug use among 1.4 million commercially insured members who were exposed to a rosiglitazone PA program beginning January 1, 2009. These members were compared with a group of approximately 2 million commercially insured members who did not have this safety PA intervention.

The study found that the rosiglitazone PA was successful in significantly reducing concurrent use of nitrates and insulin among health plan members with type 2 diabetes.

"Previous studies have found that prior authorization programs reduce drug utilization and costs, but it has been unclear whether patients were impacted positively or negatively," said Gleason. "Our study is unique in that the findings support the use of a PA to promote safe prescribing as evidenced by the potential cardiovascular event risk avoidance for patients."

The authors were: Catherine I. Starner , PharmD, BCPS,CGP; Beckie Fenrick , PharmD (formerly with Florida Blue ); Peter Wickersham , MS, MBA; and Patrick P. Gleason , PharmD, BCPS, FCCP (with Prime) and John Coleman , PharmD from Florida Blue .

The study can be found at: http://www.amcp.org/WorkArea/DownloadAsset.aspx?id=14970

The JMCP Award for Excellence entries are judged based on potential impact on the profession or knowledge, scientific merit and sound methodology, relevance to managed care pharmacy today, clarity of purpose and hypothesis, and writing quality and readability.

Prime received JMCP Award for Excellence honors in 2010 for its research examining the relationship between member out-of-pocket (OOP) costs and the number of patients who abandon high-cost specialty medications. In 2009, it was recognized for its research assessing rosiglitazone and pioglitazone utilization trends and associated medical and pharmacy claims data indicating risk for an adverse cardiovascular event.

Prime's 2012 Honorable Mention research studies will be recognized in a future issue of the AMCP Monthly News and posted on the AMCP/JMCP websites.

About Prime Therapeutics

Prime Therapeutics LLC (Prime) helps people get the medicine they need to feel better and live well. Prime manages pharmacy benefits for health plans, employers, and government programs including Medicare and Medicaid. The company processes claims and delivers medicine to members, offering clinical services for people with complex medical conditions. Headquartered in St. Paul, Minn., Prime serves more than 21 million* people. It is collectively owned by 13 Blue Cross and Blue Shield Plans, subsidiaries or affiliates of those plans. Prime has been recognized as one of the fastest-growing private companies in the nation.

*Effective July 1, 2013.


'/>"/>
SOURCE Prime Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Elsevier Selected as New Publisher of The American Journal of Geriatric Psychiatry
2. Telik Announces the Publication of Two Reports in the Journal Of Hematology & Oncology Describing the Results of a Clinical Study of Telintra® in Combination With Revlimid® and a Genomic Study Designed to Identify Genes That Predict Response to Teli
3. Study Results of Novocures NovoTTF™ Pivotal Phase 3 Trial Published in European Journal of Cancer
4. Cardiac Dimensions® Announces Publication of TITAN Clinical Trial Data in European Journal of Heart Failure
5. NAMS Journal Menopause Reflects on the WHI 10 Years Later
6. Elsevier and the Society for Vascular Surgery Announce Forthcoming Launch of Journal of Vascular Surgery: Venous and Lymphatic Disorders
7. Call for Entries: International Bureau for Epilepsy and UCB launch the 2012 Excellence in Epilepsy Journalism Award to recognize exceptional reporting on epilepsy
8. MedVantx MedStart™ Solves Problem Highlighted in Study Published in Journal of the American Board of Family Medicine - Expired Medications in Physician Office Sample Closets
9. Obesity journal publishes new study on lorcaserin, a weight-loss medication recommended for approval by FDA advisory panel
10. Lexicon Announces Publication of Results of Two Studies of LX4211 in Patients with Type 2 Diabetes in the Journal Clinical Pharmacology & Therapeutics
11. Medical Device Daily Wins Prestigious SIPA Award for Outstanding Business Journalism
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... 20, 2017  Palladian Health, a leading provider ... launch of an opioid management program which assists ... and helps stem the growing tide of dependence ... treat chronic non-cancer pain (back pain, neck pain, ... lack of evidence regarding long-term effectiveness. ...
(Date:1/20/2017)... January 20, 2017 Avillion LLP, a co-developer ... Mark Weinberg , MD MBA as Chief Medical Officer. Dr ... USA . ... Dr Weinberg has spent more than 17 years as a ... companies to micro-cap biotech. Over the course of his career, he ...
(Date:1/19/2017)... YORK , Jan. 19, 2017 Report ... Ophthalmic Devices Market? Which areas are going to grow ... potential revenues to 2026, assessing data, trends, opportunities and ... and graphs. Discover the most lucrative areas in the ... lets you assess forecasted sales across the all the ...
Breaking Medicine Technology:
(Date:1/20/2017)... Missoula, MT (PRWEB) , ... January 20, 2017 , ... Spectrum Aquatics Launches New ADA ... use, saving deck space. Since the lift is mounted on wheels, it can be wheeled ... a lock down kit, to fasten to the deck. "We have transformed the feedback from ...
(Date:1/20/2017)... ... January 20, 2017 , ... Source Vitál Apothecary, a skin and body care ... announced the company had a successful visit to the 2017 ECRM Diet, Vitamin & ... that work in the nutritional, sports and health industries a chance to meet in ...
(Date:1/20/2017)... ... January 20, 2017 , ... Lice Troopers, the lice removal company ... with school-aged children since the holiday season. , “It happens every year around ... sharing hugs and taking photos, which is the head-to-head gateway that lice need to ...
(Date:1/20/2017)... ... January 20, 2017 , ... Michael and Betsy Brauser celebrated 5 years ... Betsy, the clinical trial has been life-saving as she has been on the ... Betsy Brauser was diagnosed with ovarian cancer in 2009. She underwent standard chemotherapy but ...
(Date:1/20/2017)... ... ... “Mary Magdalene: Grace is Greater than Sin”: a unique and memorable piece ... “Mary Magdalene: Grace is Greater than Sin” is the creation of published author, Brenda ... women who had little knowledge of the female characters portrayed in the Holy Bible. ...
Breaking Medicine News(10 mins):